Business Wire

Jam City Opens Google Play Pre-Registration and Releases New Gameplay Trailer for Harry Potter: Hogwarts Mystery Mobile Game


Jam City:

This press release features multimedia. View the full release here:

Jam City's Harry Potter: Hogwarts Mystery (Graphic: Business Wire)

Jam City's Harry Potter: Hogwarts Mystery (Graphic: Business Wire)



Jam City, a Los Angeles based mobile games studio, in partnership with Warner Bros. Interactive Entertainment.



Google pre-registration for Harry Potter: Hogwarts Mystery is now open. Fans can pre-register on Google Play to be the first to be notified when the game launches. Jam City also unveiled Harry Potter: Hogwarts Mystery ’s second official trailer. Harry Potter: Hogwarts Mystery is licensed by Warner Bros. Interactive Entertainment, developed by Jam City and will be released this spring for mobile devices under Portkey Games™, the new label for gaming experiences inspired by the magic and adventures of the Wizarding World™. The title will be available on the App Store and Google Play.



Los Angeles, California


"We are grateful to the fans who have made Harry Potter: Hogwarts Mystery one of the most anticipated mobile games of 2018," said Chris DeWolfe, co-founder and CEO of Jam City. "We're thrilled to open Google pre-registration and share a new sneak peek at how this game will let fans create their own character and enter Hogwarts as a student for the first time."



To download supporting assets for Harry Potter: Hogwarts Mystery , please visit:


To view the new official trailer via YouTube, visit:


Background: Harry Potter: Hogwarts Mystery is the first mobile game where players can create their own character and experience life as a Hogwarts student. In the narrative adventure with RPG elements, players will create a personalized student avatar, attend classes, learn magical skills, and form friendships or rivalries with other students. In the game, players make pivotal decisions that influence their character’s story arc at Hogwarts. The game features a new encounter system where player decisions and actions impact their quests, allowing Harry Potter fans to create their own legacy as a witch or wizard.

For more details on Harry Potter: Hogwarts Mystery and to connect with other fans , visit,, and for more information visit

About Jam City:

Jam City is a global leader in mobile entertainment, providing social gaming experiences for millions of players around the world. Jam City was founded in 2010 by MySpace cofounders Chris DeWolfe and Aber Whitcomb, and former 20th Century Fox executive Josh Yguado. Jam City is the creative powerhouse behind some of the highest grossing and most enduring social gaming franchises for mobile, including Cookie Jam (Facebook “Game of the Year” winner) and Panda Pop. Jam City is the go-to studio for Hollywood, having developed immersive, narrative rich mobile games around iconic entertainment brands including Harry Potter, Family Guy, Marvel Avengers and Futurama. Jam City has 500 employees across studios in Los Angeles (HQ), San Francisco, San Diego, Seattle and Buenos Aires. The Jam City team is known for its creative excellence and technological innovation in key areas including storytelling, data science and audience intelligence.

About Warner Bros. Interactive Entertainment:

Warner Bros. Interactive Entertainment, a division of Warner Bros. Home Entertainment, Inc., is a premier worldwide publisher, developer, licensor and distributor of entertainment content for the interactive space across all platforms, including console, handheld, mobile and PC-based gaming for both internal and third party game titles.

About Portkey Games:

Portkey Games, from Warner Bros. Interactive Entertainment, is a games label dedicated to creating gaming experiences inspired by the magic and adventures of J.K. Rowling’s Wizarding World. These new games allow players to explore, discover and be at the center of their very own wizarding world adventure.

About the Harry Potter Series:

Harry Potter continues to be a global phenomenon. Each of the seven books by author J.K. Rowling has broken sales records, with the series to date having sold over 500 million copies worldwide and translated into 80 languages. The Harry Potter films, produced by Warner Bros. Pictures, have grossed more than $7.7 billion to date worldwide at the box office, making Harry Potter one of the largest-grossing film franchises in history.

HARRY POTTER: HOGWARTS MYSTERY software © 2018 Jam City, Inc. Developed by Jam City. Jam City® and the Jam City Logo are registered and/or unregistered trademarks of Jam City, Inc. PORTKEY GAMES © 2018 Warner Bros. Entertainment Inc. All rights reserved. HARRY POTTER and FANTASTIC BEASTS Publishing Rights © J.K. Rowling. J.K. ROWLING’S WIZARDING WORLD is a trademark of J.K. Rowling and Warner Bros. Entertainment Inc. PORTKEY GAMES, HARRY POTTER: HOGWARTS MYSTERY, HARRY POTTER and FANTASTIC BEASTS characters, names and related indicia are trademarks of and © Warner Bros. Entertainment Inc. All Rights Reserved.

WB GAMES LOGO, WB SHIELD: ™ & © Warner Bros. Entertainment Inc. (s18)

Contact information

Jam City
Sarah Ross
Kenny Johnston
ONE PR Studio (for Jam City in the US)
Kjell Vistad | Gilberto Williams-Gamboa

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on